1
|
Saura-Lázaro A, Augusto O, Fernández-Luis S, López-Varela E, Fuente-Soro L, Bila D, Tovela M, Macuacua N, Vaz P, Couto A, Bruno C, Naniche D. HIV care retention in three multi-month ART dispensing: a retrospective cohort study in Mozambique. AIDS 2024; 38:1402-1411. [PMID: 38652496 PMCID: PMC11216376 DOI: 10.1097/qad.0000000000003913] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/06/2023] [Revised: 03/14/2024] [Accepted: 03/21/2024] [Indexed: 04/25/2024]
Abstract
OBJECTIVE Evaluate the effect of three multimonth dispensing (3MMD) of antiretroviral therapy (ART) on HIV care retention in southern Mozambique. DESIGN Retrospective cohort study. METHODS We analyzed routine health data from people with HIV (PWH) aged 10 years old and older who started ART between January 2018 and March 2021. Individuals were followed until December 2021. Cox proportional-hazards models were used to compare attrition (lost to follow-up, death, and transfer out) between 3MMD and monthly ART dispensing. Results were stratified by time on ART before 3MMD enrolment: 'early enrollers' (<6 months on ART) and 'established enrollers' (≥6 months on ART), and age groups: adolescents and youth (AYLHIV) (10-24 years) and adults (≥25 years). RESULTS We included 7378 PWH (25% AYLHIV, 75% adults), with 59% and 62% enrolled in 3MMD, respectively. Median follow-up time was 11.3 [interquartile range (IQR): 5.7-21.6] months for AYLHIV and 10.2 (IQR: 4.8-20.9) for adults. Attrition was lower in PWH enrolled in 3MMD compared with monthly ART dispensing, in both established (aHR AYLHIV = 0.65; 95% CI: 0.54-0.78 and aHR adults = 0.50; 95% confidence interval (CI): 0.44-0.56) and early enrollers (aHR AYLHIV = 0.70; 95% CI: 0.58-0.85 and aHR adults = 0.63; 95% CI: 0.57-0.70). Among individuals in 3MMD, male gender (aHR = 1.30; 95% CI: 1.18-1.44) and receiving care in a medium-volume/low-volume healthcare facility (aHR = 1.18; 95% CI: 1.03-1.34) increased attrition risk. Conversely, longer ART time before 3MMD enrolment (aHR = 0.93; 95% CI: 0.92-0.94 per 1 month increase) and age at least 45 years (aHR = 0.77, 95% CI: 0.67-0.89) reduced risk of attrition. CONCLUSION 3MMD improves retention in care compared with monthly dispensing among established and early enrollers, although to a lesser extent among the latter.
Collapse
Affiliation(s)
- Anna Saura-Lázaro
- ISGlobal, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain
| | - Orvalho Augusto
- Centro de Investigação em Saúde de Manhiça (CISM)
- Faculdade de Medicina, Universidade Eduardo Mondlane, Maputo, Mozambique
- Department of Global Health, University of Washington, Seattle, Washington, USA
| | - Sheila Fernández-Luis
- ISGlobal, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain
- Centro de Investigação em Saúde de Manhiça (CISM)
| | - Elisa López-Varela
- ISGlobal, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain
- Centro de Investigação em Saúde de Manhiça (CISM)
| | - Laura Fuente-Soro
- ISGlobal, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain
- Centro de Investigação em Saúde de Manhiça (CISM)
| | - Dulce Bila
- Fundação Ariel Glaser Contra o SIDA Pediatrico
| | | | | | - Paula Vaz
- Fundação Ariel Glaser Contra o SIDA Pediatrico
| | - Aleny Couto
- Programa Nacional de Controle de HIV/SIDA, Ministério da Saúde
| | - Carmen Bruno
- Direcção Provincial de Saúde, Maputo, Mozambique
| | - Denise Naniche
- ISGlobal, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain
- Centro de Investigação em Saúde de Manhiça (CISM)
| |
Collapse
|
2
|
Likoko S, Akokuwebe ME, Osuafor GN, Idemudia ES. "Health Outcomes of Grandparents Caring for Double Orphans in South Africa": What Are the Determinants? INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2023; 20:7158. [PMID: 38131710 PMCID: PMC10743013 DOI: 10.3390/ijerph20247158] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/02/2023] [Revised: 12/04/2023] [Accepted: 12/04/2023] [Indexed: 12/23/2023]
Abstract
In the 21st century, grandparenthood is a significant phenomenon in the fields of demography, gerontology, and sociology. It is mainly explored in the context of ageing, as it is poised to become one of the most significant demographic phenomena and social issues in contemporary South Africa. Therefore, this study examined the determinants associated with grandparents who are parenting as caregivers and the health challenges they are exposed to as caregivers. The National Income Dynamics Study (NIDS) Wave 5 dataset was utilised, and a total of 302,476 grandparents aged 25 years and older, who were reported to be primary caregivers of double orphans, were included in the analysis. Both bivariate and multivariate binary logistic regressions were performed to determine the predictors of the determinants of grandparents parenting as caregivers and their health challenges in South Africa. Estimated odds ratios (ORs) with 95% confidence intervals (CIs) were used, and the threshold for statistical significance was established at ρ < 0.05. A majority of the male and female grandparent caregivers were aged 24-34 years, were Black Africans (69.8%), had secondary education (46.9%), reported health challenges (HC) (59.7%), with 26.4% reporting headaches in the last 30 days. Logistic regression revealed that grandparent caregivers aged 55-64 years were 8.9 times more likely to report health challenges compared to those aged 25-34 years. Non-Black African grandparent caregivers were found to be 0.61 times less likely to report health challenges, compared to Black African grandparent caregivers. Those with perceived poor health status were 3.3 times more likely to report health challenges, compared to those with excellent perceived health status. Therefore, there is an urgent need to redesign health interventions to address these health burdens among grandparent caregivers and to take cognisance of providing economic and social support for these vulnerable populations.
Collapse
Affiliation(s)
- Salmon Likoko
- Statistics South Africa, ISIbalo House, Pretoria 0002, South Africa;
| | | | - Godswill Nwabuisi Osuafor
- Department of Population Studies and Demography, North-West University, Mafikeng 2735, South Africa;
| | | |
Collapse
|
3
|
Manjate F, Quintó L, Chirinda P, Acácio S, Garrine M, Vubil D, Nhampossa T, João ED, Nhacolo A, Cossa A, Massora S, Bambo G, Bassat Q, Kotloff K, Levine M, Alonso PL, Tate JE, Parashar U, Mwenda JM, Mandomando I. Impact of rotavirus vaccination on diarrheal hospitalizations in children younger than 5 years of age in a rural southern Mozambique. Vaccine 2022; 40:6422-6430. [PMID: 36192272 PMCID: PMC9589241 DOI: 10.1016/j.vaccine.2022.09.050] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2022] [Revised: 09/15/2022] [Accepted: 09/16/2022] [Indexed: 01/27/2023]
Abstract
BACKGROUND Rotavirus vaccine(Rotarix®) was introduced in Mozambique through its Expanded Program of Immunization in September 2015. We assessed the impact of rotavirus vaccination on childhood gastroenteritis-associated hospitalizations post-vaccine introduction in a high HIV prevalence rural setting of southern Mozambique. METHODS We reviewed and compared the trend of hospitalizations (prevalence) and incidence rates of acute gastroenteritis (AGE), and rotavirus associated-diarrhea (laboratory confirmed rotavirus) in pre- (January 2008-August 2015) and post-rotavirus vaccine introduction periods (September 2015-December 2020), among children <5 years of age admitted to Manhiça District Hospital. RESULTS From January 2008 to December 2020, rotavirus vaccination was found to contribute to the decline of the prevalence of AGE from 19% (95% CI: 18.14-20.44) prior to the vaccine introduction to 10% (95% CI: 8.89-11.48) in the post-introduction period, preventing 40% (95 % IE: 38-42) and 84% (95 % IE: 80-87) of the expected AGE and laboratory confirmed rotavirus cases, respectively, among infants. Similarly, the overall incidence of rotavirus was 11.8-fold lower in the post-vaccine introduction period (0.4/1000 child-years-at-risk [CYAR]; 95% CI: 0.3-0.6) compared with the pre-vaccination period (4.7/1000 CYAR; 95% CI: 4.2-5.1) with the highest reduction being observed among infants (16.8-fold lower from the 15.1/1000 CYAR in the pre-vaccine to 0.9/1000 CYAR in the post-vaccine eras). CONCLUSIONS We documented a significant reduction in all-cause diarrhea hospitalizations and rotavirus positivity after vaccine introduction demonstrating the beneficial impact of rotavirus vaccination in a highly vulnerable population.
Collapse
Affiliation(s)
- Filomena Manjate
- Centro de Investigação em Saúde de Manhiça (CISM), Maputo 1929, Mozambique; Global Health and Tropical Medicine (GHTM), Instituto de Higiene e Medicina Tropical (IHMT), Universidade Nova de Lisboa (UNL), 1349-008 Lisbon, Portugal.
| | - Llorenç Quintó
- Centro de Investigação em Saúde de Manhiça (CISM), Maputo 1929, Mozambique; Barcelona Institute for Global Health (ISGlobal), Hospital Clínic - Universitat de Barcelona, 08036 Barcelona, Spain.
| | - Percina Chirinda
- Centro de Investigação em Saúde de Manhiça (CISM), Maputo 1929, Mozambique.
| | - Sozinho Acácio
- Centro de Investigação em Saúde de Manhiça (CISM), Maputo 1929, Mozambique; Instituto Nacional de Saúde (INS), Ministério da Saúde, Marracuene 1120, Mozambique.
| | - Marcelino Garrine
- Centro de Investigação em Saúde de Manhiça (CISM), Maputo 1929, Mozambique; Global Health and Tropical Medicine (GHTM), Instituto de Higiene e Medicina Tropical (IHMT), Universidade Nova de Lisboa (UNL), 1349-008 Lisbon, Portugal.
| | - Delfino Vubil
- Centro de Investigação em Saúde de Manhiça (CISM), Maputo 1929, Mozambique.
| | - Tacilta Nhampossa
- Centro de Investigação em Saúde de Manhiça (CISM), Maputo 1929, Mozambique; Instituto Nacional de Saúde (INS), Ministério da Saúde, Marracuene 1120, Mozambique.
| | - Eva D João
- Centro de Investigação em Saúde de Manhiça (CISM), Maputo 1929, Mozambique.
| | - Arsénio Nhacolo
- Centro de Investigação em Saúde de Manhiça (CISM), Maputo 1929, Mozambique.
| | - Anelsio Cossa
- Centro de Investigação em Saúde de Manhiça (CISM), Maputo 1929, Mozambique.
| | - Sérgio Massora
- Centro de Investigação em Saúde de Manhiça (CISM), Maputo 1929, Mozambique.
| | - Gizela Bambo
- Centro de Investigação em Saúde de Manhiça (CISM), Maputo 1929, Mozambique.
| | - Quique Bassat
- Centro de Investigação em Saúde de Manhiça (CISM), Maputo 1929, Mozambique; Barcelona Institute for Global Health (ISGlobal), Hospital Clínic - Universitat de Barcelona, 08036 Barcelona, Spain; ICREA, Pg. Lluís Companys 23, 08010 Barcelona, Spain; Pediatrics Department, Hospital Sant Joan de Déu, (University of Barcelona), 2, 08950, Barcelona, Spain; Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
| | - Karen Kotloff
- Center for Vaccine Development (CVD), University of Maryland School of Medicine, Baltimore, MD 21201, USA.
| | - Myron Levine
- Center for Vaccine Development (CVD), University of Maryland School of Medicine, Baltimore, MD 21201, USA.
| | - Pedro L Alonso
- Centro de Investigação em Saúde de Manhiça (CISM), Maputo 1929, Mozambique; Barcelona Institute for Global Health (ISGlobal), Hospital Clínic - Universitat de Barcelona, 08036 Barcelona, Spain; Global Malaria Programme, World Health Organization, 1211 Geneva, Switzerland
| | - Jacqueline E Tate
- Centers for Disease Control and Prevention (CDC), Atlanta, GA 30333, USA.
| | - Umesh Parashar
- Centers for Disease Control and Prevention (CDC), Atlanta, GA 30333, USA
| | - Jason M Mwenda
- African Rotavirus Surveillance Network, Immunization, Vaccines and Development Program, World Health Organization, Regional Office for Africa, Brazzaville P.O. Box 2465, Congo.
| | - Inácio Mandomando
- Centro de Investigação em Saúde de Manhiça (CISM), Maputo 1929, Mozambique; Instituto Nacional de Saúde (INS), Ministério da Saúde, Marracuene 1120, Mozambique.
| |
Collapse
|